Found: 16
Select item for more details and to access through your institution.
Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.
- Published in:
- BJU International, 2011, v. 108, n. 2b, p. E142, doi. 10.1111/j.1464-410X.2010.09810.x
- By:
- Publication type:
- Article
Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin.
- Published in:
- BJU International, 2011, v. 107, n. 7, p. 1148, doi. 10.1111/j.1464-410X.2010.09535.x
- By:
- Publication type:
- Article
Organ-Specific Tumor Response to Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 5, p. N.PAG, doi. 10.1016/j.clgc.2024.102148
- By:
- Publication type:
- Article
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 5, p. 499.e1, doi. 10.1016/j.clgc.2022.05.001
- By:
- Publication type:
- Article
Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
- Published in:
- In Vivo, 2021, v. 35, n. 5, p. 2869, doi. 10.21873/invivo.12575
- By:
- Publication type:
- Article
The significance of strong histone deacetylase 1 expression in the progression of prostate cancer.
- Published in:
- Histopathology, 2011, v. 58, n. 5, p. 773, doi. 10.1111/j.1365-2559.2011.03797.x
- By:
- Publication type:
- Article
Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1, and androgen receptor.
- Published in:
- Prostate, 2013, v. 73, n. 12, p. 1336, doi. 10.1002/pros.22681
- By:
- Publication type:
- Article
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 1641, doi. 10.2147/CMAR.S360473
- By:
- Publication type:
- Article
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8049, doi. 10.2147/CMAR.S333823
- By:
- Publication type:
- Article
Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy.
- Published in:
- Cancer Science, 2011, v. 102, n. 3, p. 639, doi. 10.1111/j.1349-7006.2010.01828.x
- By:
- Publication type:
- Article
Transformation of hard pollen into soft matter.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15294-w
- By:
- Publication type:
- Article
Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single‐center prospective randomized controlled trial (VAPOR TRIAL).
- Published in:
- LUTS, 2024, v. 16, n. 4, p. 1, doi. 10.1111/luts.12529
- By:
- Publication type:
- Article
A prospective, single‐center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180‐W GreenLight XPS laser, a 300‐W diode laser, and a 200‐W thulium laser for the treatment of benign prostatic hyperplasia
- Published in:
- LUTS, 2022, v. 14, n. 5, p. 373, doi. 10.1111/luts.12453
- By:
- Publication type:
- Article
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 1321, doi. 10.2147/OTT.S389138
- By:
- Publication type:
- Article
Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 1981, doi. 10.2147/OTT.S299724
- By:
- Publication type:
- Article
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study.
- Published in:
- Current Oncology, 2024, v. 31, n. 2, p. 862, doi. 10.3390/curroncol31020064
- By:
- Publication type:
- Article